Sources | Names Used |
---|---|
CTRPv2 | selumetinib:UNC0638 (4:1 mol/mol) |
PharmacoGx | selumetinib:UNC0638 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LAS1L | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-07 |
mRNA | FUT4 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | HRH2 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | UPF3B | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-07 |
mRNA | MSANTD3-TMEFF1 | CTRPv2 | pan-cancer | AAC | -0.21 | 9e-07 |
mRNA | MIS18A | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
mRNA | HNRNPR | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
mRNA | USP30 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-07 |
mRNA | ZNF250 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
mRNA | EXO1 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |